利福昔明 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "利福昔明" in Chinese language version.

refsWebsite

Global rank Chinese rank

8nih.gov

4^th place

5^th place

7doi.org

2^nd place

23^rd place

3web.archive.org

1^st place

2drugs.com

399^th place

208^th place

1archive.org

6^th place

4^th place

archive.org (Global: 6^th place; Chinese: 4^th place)

Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin. Clinical Infectious Diseases. March 2007, 44 (6): 846–8. PMID 17304459. doi:10.1086/511870.

doi.org (Global: 2^nd place; Chinese: 23^rd place)

Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome. Expert Rev Gastroenterol Hepatol. 2016, 10 (4): 431–42. PMID 26753693. doi:10.1586/17474124.2016.1140571.
Rifaximin for the treatment of irritable bowel syndrome - a drug safety evaluation. Expert Opinion on Drug Safety. July 2016, 15 (7): 983–91. PMID 27149541. doi:10.1080/14740338.2016.1186639.
Clinical Practice Guidelines for Irritable Bowel Syndrome in Korea, 2017 Revised Edition. Journal of Neurogastroenterology and Motility. April 2018, 24 (2): 197–215. PMC 5885719 . PMID 29605976. doi:10.5056/jnm17145.
Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin. Clinical Infectious Diseases. March 2007, 44 (6): 846–8. PMID 17304459. doi:10.1086/511870.
A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection. The Journal of Antimicrobial Chemotherapy. December 2011, 66 (12): 2850–5. PMID 21948965. doi:10.1093/jac/dkr377.
Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults. The Cochrane Database of Systematic Reviews. March 2017, 3: CD004610. PMC 6464548 . PMID 28257555. doi:10.1002/14651858.CD004610.pub5.
Profile of rifaximin and its potential in the treatment of irritable bowel syndrome. Clin Exp Gastroenterol. 2015, 8: 159–67. PMC 4467648 . PMID 26089696. doi:10.2147/CEG.S67231.

drugs.com (Global: 399^th place; Chinese: 208^th place)

Rifaximin international. Drugs.com. 2 November 2020 [11 November 2020]. （原始内容存档于2023-07-14）.
Rifaximin. The American Society of Health-System Pharmacists. [8 January 2017]. （原始内容存档于2020-03-01）.

nih.gov (Global: 4^th place; Chinese: 5^th place)

ncbi.nlm.nih.gov

Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome. Expert Rev Gastroenterol Hepatol. 2016, 10 (4): 431–42. PMID 26753693. doi:10.1586/17474124.2016.1140571.
Rifaximin for the treatment of irritable bowel syndrome - a drug safety evaluation. Expert Opinion on Drug Safety. July 2016, 15 (7): 983–91. PMID 27149541. doi:10.1080/14740338.2016.1186639.
Clinical Practice Guidelines for Irritable Bowel Syndrome in Korea, 2017 Revised Edition. Journal of Neurogastroenterology and Motility. April 2018, 24 (2): 197–215. PMC 5885719 . PMID 29605976. doi:10.5056/jnm17145.
Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin. Clinical Infectious Diseases. March 2007, 44 (6): 846–8. PMID 17304459. doi:10.1086/511870.
A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection. The Journal of Antimicrobial Chemotherapy. December 2011, 66 (12): 2850–5. PMID 21948965. doi:10.1093/jac/dkr377.
Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults. The Cochrane Database of Systematic Reviews. March 2017, 3: CD004610. PMC 6464548 . PMID 28257555. doi:10.1002/14651858.CD004610.pub5.
Profile of rifaximin and its potential in the treatment of irritable bowel syndrome. Clin Exp Gastroenterol. 2015, 8: 159–67. PMC 4467648 . PMID 26089696. doi:10.2147/CEG.S67231.

dailymed.nlm.nih.gov

Xifaxan- rifaximin tablet. DailyMed. 1 October 2019 [11 November 2020]. （原始内容存档于2023-03-22）.

web.archive.org (Global: 1^st place; Chinese: 1^st place)

Rifaximin international. Drugs.com. 2 November 2020 [11 November 2020]. （原始内容存档于2023-07-14）.
Xifaxan- rifaximin tablet. DailyMed. 1 October 2019 [11 November 2020]. （原始内容存档于2023-03-22）.
Rifaximin. The American Society of Health-System Pharmacists. [8 January 2017]. （原始内容存档于2020-03-01）.

利福昔明 (Chinese Wikipedia)

archive.org (Global: 6th place; Chinese: 4th place)

doi.org (Global: 2nd place; Chinese: 23rd place)

drugs.com (Global: 399th place; Chinese: 208th place)

nih.gov (Global: 4th place; Chinese: 5th place)